AI SummaryIndia's urban sewage systems contain widespread antimicrobial resistance genes—a ₹450–600 crore diagnostic opportunity as municipalities and health authorities mandate localized AMR surveillance following CSIR-CCMB's 2025 findings. Tier-1 cities (Delhi, Bangalore, Hyderabad, Mumbai) and state health departments are actively seeking affordable real-time testing capacity; government investment in water safety and WHO pressure on AMR tracking create favorable 2026 timing. Biotech entrepreneurs with NABL capability and municipal relationships should establish regional labs immediately.
Loading...